Alberto Zaniboni

Fondazione Poliambulanza Istituto Ospedaliero — Italy

Medicine · Health Sciences

57h-index16.2kcitations495works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(275), Cancer Treatment and Pharmacology(127), Gastric Cancer Management and Outcomes(122), Lung Cancer Treatments and Mutations(75), Pancreatic and Hepatic Oncology Research(60)

Publications488 total

Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left-sided RAS/BRAF wild-type metastatic colorectal cancer: the IMPROVE-2 trial
2025Open Access
A New Model for Bone Health Management in Postmenopausal Early Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy—The Predict & Prevent Project
Healthcare·2025Open Access
Training gut and body: physical activity, diet, ASA and microbiota influence the outcome in gastrointestinal cancer survivors
Frontiers in Nutrition·2025· 1 citedOpen Access
Clinical Evidence for Microbiome-Based Strategies in Cancer Immunotherapy: A State-of-the-Art Review
Medicina·2025· 3 citedOpen Access
FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials
European Journal of Cancer·2025· 2 cited
A systematic review and network meta-analysis of immune checkpoint inhibitors in operable NSCLC: neoadjuvant, adjuvant, or perioperative?
Translational Lung Cancer Research·2025Open Access
Role of diet, physical activity and new drugs in the primary management of cancer cachexia in gastrointestinal tumors – a comprehensive review
Frontiers in Oncology·2025· 4 citedOpen Access
What Is Next for Refractory Colorectal Cancer CRC? Looking Beyond SUNLIGHT, FRESCO2, RECURSE and CORRECT
International Journal of Molecular Sciences·2025· 6 citedOpen Access
The use of liquid biopsy comprehensive genomic profiling to identify the molecular landscape of patients with metastatic colorectal cancer who are candidates for anti-EGFR rechallange therapy: Findings from the CAVE-2 GOIM trial.
Journal of Clinical Oncology·2025· 1 cited
A therapeutic algorithm guiding subsequent therapy selection after CDK4/6 inhibitors’ failure: A review of current and investigational treatment for HR+/Her2- breast cancer
Critical Reviews in Oncology/Hematology·2024· 5 cited
Which therapy in biliary tract cancer? Review of main concerns in diagnosis and choice of therapy in advanced setting, current standard, and new options
Expert Opinion on Pharmacotherapy·2024
The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort Study
Annals of Surgical Oncology·2024· 9 citedOpen Access
FOLFOXIRI/bevacizumab (bev) versus doublets/bev as initial therapy of unresectable liver-only, right-sided and/or <i>RAS</i> or <i>BRAF</i> mutated (mut) metastatic colorectal cancer (mCRC): An individual patient data-based pooled analysis of randomized trials.
Journal of Clinical Oncology·2024
Effect of p16 immunohistochemical expression (exp) on irinotecan in metastatic colorectal cancer (mCRC): A translational analysis of the TRIBE and TRIBE2 studies.
Journal of Clinical Oncology·2024
56P Systemic inflammation in liver vs non-liver metastatic microsatellite stable (MSS) colorectal cancer (CRC): An analysis of 2186 patients (pts) from the observational study BMI-QoL and the phase II and III trials MACBETH, MOMA, ATEZOTRIBE, TRIBE, TRIBE2, TRIPLETE
Annals of Oncology·2024Open Access
Negative hyperselection and mechanisms of acquired resistance to first-line chemotherapy plus anti-EGFR in patients (pts) with pMMR <i>RAS/BRAF</i> wild-type (wt) metastatic colorectal cancer (mCRC): A translational analysis of the TRIPLETE trial.
Journal of Clinical Oncology·2024· 1 cited
Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review
Annals of Surgical Oncology·2024· 6 citedOpen Access
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis
Current Problems in Cancer·2024· 4 cited
Sunglasses for Sunlight: Considerations on New Treatment Opportunities for Refractory Colorectal Cancer
Cancers·2024· 1 citedOpen Access
Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials
Medicina·2024· 5 citedOpen Access
page 1 of 25Next →

Frequent Co-authors

Alfredo Falcone(19), Sara Lonardi(17), Roberto Labianca(16), Chiara Cremolini(13), Fotios Loupakis(13), Gianluca Tomasello(12), Stefano Cascinu(12), Sandro Barni(10), Filippo de Braud(9), Giuseppe Tonini(8), Gianluca Masi(8), Mario Scartozzi(8), Monica Ronzoni(7), Luca Boni(7), Vittorina Zagonel(7), Angela Buonadonna(7), Filippo Pietrantonio(7), Rossana Berardi(7), Cristina Granetto(6), Enrico Cortesi(6)